BPI-2361

N/A

Report date: 2022/05/10 11:43:24

NME

Base Information

Drug NameBPI-2361

Drug Alias NameBPI2361

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulators

TargetsGTPase KRas

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBeta Pharma Inc

China Registration ClassN/A

Active CompaniesBeta Pharma Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A